Syncom Formulations (India) Limited announced that tenure completion of Shri Vinod Kumar Kabra, Shri Krishna Das Neema and Shri Praveen Jindal Independent Director(s) of the Company appointed w.e.f., 1 April, 2014 for a tenure of five (5) year and further were re-appointed w.e.f. 1 April, 2019 for further tenure of five (5) year in the category of Non-Executive Independent Directors of the company w.e.f. close of working hour of 31 March, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.88 INR | +1.54% | +0.07% | -7.71% |
Mar. 29 | Syncom Formulations Limited Announces Board Changes | CI |
Feb. 14 | Syncom Formulations Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-7.71% | 154M | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.70% | 147B |
- Stock Market
- Equities
- SYNCOMF Stock
- News Syncom Formulations (India) Limited
- Syncom Formulations Limited Announces Board Changes